Notícias Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product - AKN | Ações American Stock Exchange | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN)
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN) Notícias

Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN)

0,00

0,00

(0,00%)

Fechado 10 Março 5:00PM

Atrasado por 15 minutos

0,00

0,00

( 0,00% )

Pré-mercado: -

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

- Securities Registration (section 12(b)) (8-A12B)

-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)

Safety First Trust Series 2006-5 - Prospectus filed pursuant to Rule 424(b)(2) (424B2)

Safety First Trust Series 2006-5 - Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)

American Stock Exchange Lists Safety First Trust Series 2007-4 Principal-Protected Trust Certificates Linked to a Global Index B

Akorn, Inc. Signs an Exclusive Supply Agreement For Hydase(TM) (Hyaluronidase Injection, USP) 150 Units/mL, an NDA Product

Akorn, Inc. Announces Move to Nasdaq Global Market

Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)

Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products

Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine AND

Akorn, Inc. and Serum Institute of India, Ltd. Announce the Signing of a Definitive Development and Exclusive Distribution Agree

Akorn, Inc. and Natco Pharma Limited Add Two Injectable Drug Products To API Supply and Margin Sharing Agreement

Akorn, Inc. Reports Third Quarter 2006 Revenues of $14.5 million and 41% Gross Margin

Akorn, Inc. Announces Third Quarter 2006 Earnings Release and Conference Call Information

Akorn Announces $3.5 Million Purchase Order For Calcium-DTPA and Zinc-DTPA

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições